Turkish Journal of Medical Sciences
DOI
10.55730/1300-0144.5528
Abstract
Background/aim: Acute pancreatitis is a clinical picture with a wide range of symptoms from mild inflammation to multiorgan failure and death. The aim of this study is to investigate the effects of Adalimumab (ADA) on inflammation and apoptosis in a cerulein-induced acute pancreatitis model in rats. Material and methods: Experimental cerulein-induced acute pancreatitis model was created by applying 4 intraperitoneal cerulein injections at 1-h intervals. A total of 40 rats, 8 in each group, were randomly distributed into five groups. In the groups that ADA treatment was given, two different doses of ADA were administered 5 mg/kg and 20 mg/kg as low and high doses, respectively. The rats were sacrificed 12 h after the last intraperitoneal administration of ADA. Blood samples were obtained from each rat for amylase, IL-6, and IL-1ß measurements. Hematoxylin and Eosin (H&E) stains were used to undertake the histopathological analysis of the pancreas. The terminal deoxynucleotidyl transferase-mediated nick-end-labeling (TUNEL) method was used to evaluate apoptosis. Results: Plasma amylase, IL-6, and IL-1ß levels were significantly elevated in acute pancreatitis groups (p < 0.05). It was determined that both low (5 mg/kg) and high doses (20 mg/kg) of ADA ameliorated the parameters (plasma amylase, IL-6, and IL-1ß) (p < 0.05). Although significant improvements were detected in the Schoenberg scoring system and the apoptotic index from the TUNEL method after highdose ADA treatment, no significant amelioration was observed in the histopathological examinations in the low-dose ADA group. Conclusions: It has been determined that the administration of high-dose ADA effectively alleviated the symptoms of acute pancreatitis and reduced the level of apoptosis. In line with the findings of our study, we have predicted that high-dose (20 mg/kg) ADA can be used as an effective and safe drug in the treatment of patients with acute pancreatitis.
Keywords
Acute pancreatitis, Adalimumab, inflammation, apoptosis
First Page
1821
Last Page
1828
Recommended Citation
GÜNEY, BAŞAK ÇAKIR; TANOĞLU, ALPASLAN; YENİÇERİ, MURAT; ÇIRAK, ZAFER; SADE, AYŞE GÖKÇEN; TAŞTAN, YEŞİM ÖNAL; SERİNDAĞ, ZELİHA; and KAPLAN, MUSTAFA
(2022)
"Favorable efficacy of adalimumab treatment in experimental acute pancreatitis model,"
Turkish Journal of Medical Sciences: Vol. 52:
No.
6, Article 11.
https://doi.org/10.55730/1300-0144.5528
Available at:
https://journals.tubitak.gov.tr/medical/vol52/iss6/11